Patent ID: 11884725
Assignee: AMPSOURCE BIOPHARMA SHANGHAI INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 2:
3. The antibody or the antigen-binding fragment thereof according to claim 2, comprising:
(1) three CDRs contained in the heavy chain variable region (VH) as shown by SEQ ID NO: 1, and/or three CDRs contained in the light chain variable region (VL) as shown by SEQ ID NO: 2;
wherein the three CDRs contained in the heavy chain variable region (VH) and the three CDRs contained in the light chain variable region (VL) are defined by the IMGT numbering system;
(2) (a) three CDRs contained in the heavy chain variable region (VH) as shown by SEQ ID NO: 1, and/or three CDRs contained in the light chain variable region (VL) as shown by SEQ ID NO: 2; or (b) three CDRs contained in the heavy chain variable region (VH) as shown by SEQ ID NO: 7, and/or three CDRs contained in the light chain variable region (VL) as shown by SEQ ID NO: 8;
wherein the three CDRs contained in the heavy chain variable region (VH) and the three CDRs contained in the light chain variable region (VL) are defined by the Kabat numbering system; or
(3) three CDRs contained in the heavy chain variable region (VH) as shown by SEQ ID NO: 1, and/or three CDRs contained in the light chain variable region (VL) as shown by SEQ ID NO: 2;
wherein the three CDRs contained in the heavy chain variable region (VH) and the three CDRs contained in the light chain variable region (VL) are defined by the Chothia numbering system.